TCW funds, an investment management company, released its “TCW Relative Value Large Cap Fund” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. Equities ended the year ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Merck & Co., Inc. (NYSE:MRK) is one of the 10 Most Profitable S&P 500 Stocks to Buy Now. On March 20, 2026, Citi raised the price target on Merck & Co., Inc. (NYSE:MRK) to $125 from $120 and ...

After generating interest from the likes of Pfizer and GSK, Quotient Therapeutics’ somatic genomics platform has attracted another Big Pharma suitor in Merck & Co. Looking to devise new drug targets ...

Joseph Romanelli, President at Merck & Co (NYSE:MRK), reported an insider buy on January 28, according to a new SEC filing. What Happened: Romanelli made a significant move by purchasing 5,703 shares ...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the Board of Directors has declared a quarterly dividend of $0.85 per share ...

Merck & Co (NYSE:MRK) underwent analysis by 13 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. In the table below, you'll find a summary of their recent ...

Merck & Co. is no longer in talks to acquire biotech firm Revolution Medicines Inc. after the two companies couldn’t agree on a price, the Wall Street Journal reported , citing people familiar with ...

For the better part of a year, Merck & Co. and Halozyme have been locked in an intellectual property disagreement over the the pharma giant's new, under-the-skin version of cancer megablockbuster ...

Halozyme was granted a preliminary injunction that would prevent Merck & Co. from distributing a formulation of Keytruda in Germany as part of a patent-infringement dispute over the cancer treatment.

Merck & Co. logo displayed on the exterior of their research facility in San Francisco, Calif., on Sep. 21, 2020. This story was originally published on BioPharma Dive. To receive daily news and ...